首页> 外文期刊>Chembiochem: A European journal of chemical biology >Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism
【24h】

Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism

机译:线性非核糖体肽合成酶机制生物合成肽类抗生素烟曲霉素

获取原文
获取原文并翻译 | 示例
           

摘要

Feglymycin, a peptide antibiotic produced by Streptomyces sp. DSM11171, consists mostly of nonproteinogenic phenylglycine-type amino acids. It possesses antibacterial activity against methicillin-resistant Staphylococcus aureus strains and antiviral activity against HIV. Inhibition of the early steps of bacterial peptidoglycan synthesis indicated a mode of action different from those of other peptide antibiotics. Here we describe the identification and assignment of the feglymycin (feg) biosynthesis gene cluster, which codes for a 13-module nonribosomal peptide synthetase (NRPS) system. Inactivation of an NRPS gene and supplementation of a hydroxymandelate oxidase mutant with the amino acid L-Hpg proved the identity of the feg cluster. Feeding of Hpg-related unnatural amino acids was not successful. This characterization of the feg cluster is an important step to understanding the biosynthesis of this potent antibacterial peptide.
机译:Feglymycin,一种由链霉菌属产生的肽抗生素。 DSM11171主要由非蛋白质的苯基甘氨酸型氨基酸组成。它对耐甲氧西林的金黄色葡萄球菌菌株具有抗菌活性,对HIV具有抗病毒活性。细菌肽聚糖合成的早期步骤的抑制表明其作用方式不同于其他肽类抗生素。在这里,我们描述了feglymycin(feg)生物合成基因簇的鉴定和分配,该簇编码13个模块的非核糖体肽合成酶(NRPS)系统。 NRPS基因的失活和氨基酸L-Hpg补充羟基扁桃酸酯氧化酶突变体证明了feg簇的身份。 Hpg相关的非天然氨基酸的饲喂不成功。 feg簇的表征是了解该有效抗菌肽生物合成的重要步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号